利用微流控技术应对COVID-19和其他肺部疾病的全球挑战

作     者：Yuliang Xie Ryan Becker Michael Scott Kayla Bean Tony Jun Huang Yuliang Xie;Ryan Becker;Michael Scott;Kayla Bean;Tony Jun Huang

作者机构：Roy J.Carver Department of Biomedical EngineeringCollege of EngineeringUniversity of IowaIowa CityIA 52242USA Department of Biomedical EngineeringPratt School of EngineeringDuke UniversityDurhamNC 27710USA Department of Mechanical Engineering and Materials SciencePratt School of EngineeringDuke UniversityDurhamNC 27710USA 

出 版 物：《Engineering》 (工程（英文）)

年 卷 期：2023年第24卷第5期

页      面：17-20,I0001页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：support from the National Institutes of Health (U18TR003778, R01GM141055, R01GM132603, and R01GM135486) National Science Foundation (ECCS-1807601) to Tony Jun Huang Roy J. Carver faculty start-up fund University of Iowa to Yuliang Xie 

主　　题：微流控技术 肺部疾病 全球挑战 

摘      要：1. Introduction Pulmonary diseases present one of the most severe threats to human society. Since late 2019, the coronavirus disease 2019(COVID-19) pandemic has significantly impacted the lifestyle, culture, and politics of almost everyone in the world. COVID-19 causes severe pulmonary dysfunction, which is a major cause of mortality for those affected [1].